The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global urinary incontinence devices market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Urinary incontinence is a medical condition that leads to the involuntary loss of urine. It is treated using medical devices, which help build and strengthen pelvic floor muscles and treat chronic urinary incontinence. These devices include electrical muscle stimulation that assists in the effective, safe, and non-invasive treatment of stress, urge, and mixed urinary incontinence. Presently, several manufacturers are developing purpose-based devices for the female population. They are introducing a wide range of small, tampon-like disposable devices for everyday activities and flexible silicone rings to prevent urine leakage and support the urethra in women with vaginal prolapse.
Neurological diseases, diabetes and obesity, along with the consumption of foods like caffeine, sweeteners, chocolates, carbonated drinks, sparkling water, artificial chili peppers, and muscle relaxants can increase the risk of urinary incontinence. This, in confluence with a significant rise in the number of individuals who smoke and drink and are suffering from chronic diseases, represents one of the key factors bolstering the market growth. Moreover, urinary incontinence increases due to advancing age. As a result, the growing geriatric population is positively influencing the demand for urinary incontinence devices around the world. Apart from this, the emerging trend of non-invasive treatment options is driving the utilization of at-home devices to treat stress, urge, and bowel incontinence. Furthermore, leading manufacturers are offering innovative products to expand their product portfolio and gain a competitive edge. For instance, Kimberly-Clark Corporation, US-based sanitary products and surgical and medical instruments manufacturing company, launched the Poise Active Collection of ultra-thin pads and liners for women. These thin, absorbent pads and liners instantly absorb and help lock in wetness and odor.
IMARC Group provides an analysis of the key trends in each sub-segment of the global urinary incontinence devices market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, category, incontinence type, patient and end user.
Breakup by Product:
Breakup by Category:
Breakup by Incontinence Type:
Breakup by Patient:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc, Becton Dickinson and Company, Boston Scientific Corporation, Caldera Medical Inc., Coloplast A/S, ConvaTec Group plc, Cook Group Inc., Johnson & Johnson, Kimberly-Clark Corporation, Laborie Medical Technologies Inc., Medtronic plc and Teleflex Incorporated.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Category, Incontinence Type, Patient, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||B. Braun Melsungen AG, Baxter International Inc, Becton Dickinson and Company, Boston Scientific Corporation, Caldera Medical Inc., Coloplast A/S, ConvaTec Group plc, Cook Group Inc., Johnson & Johnson, Kimberly-Clark Corporation, Laborie Medical Technologies Inc., Medtronic plc and Teleflex Incorporated.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at